David Rolfe - Wedgewood Partners Inc
Holding/activity history for Bristol-Myers Squibb Cocontngn (BMY-R)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2021 Q1 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2020 Q4 | 122,750 | 0.01 | Reduce 6.69% | <0.01 | $0.68 | $84,000 | SEC |
| 2020 Q3 | 131,557 | 0.05 | Reduce 2.35% | <0.01 | $2.24 | $295,000 | SEC |
| 2020 Q2 | 134,729 | 0.08 | Reduce 9.52% | 0.01 | $3.57 | $481,000 | SEC |
| 2020 Q1 | 148,901 | 0.11 | Buy | 0.11 | $3.79 | $565,000 | SEC |